Congress Asset Management Cuts Boston Scientific Stake

Investment firm reduces holdings in medical device company by 2%

Mar. 24, 2026 at 8:37am

Got story updates? Submit your updates here. ›

Congress Asset Management Co. reduced its stake in Boston Scientific Corporation by 2% during the fourth quarter, according to a recent SEC filing. The investment firm now owns approximately 1.65 million shares of the medical equipment provider, valued at $157.32 million.

Why it matters

Boston Scientific is a major player in the medical device industry, and changes in institutional ownership of its stock can signal shifts in investor sentiment and market trends around the company.

The details

Congress Asset Management sold 34,119 shares of Boston Scientific during the fourth quarter, bringing its total holdings down to 1,649,958 shares. The firm's position in Boston Scientific now makes up about 1.1% of its overall portfolio.

  • Congress Asset Management filed its 13F report for the fourth quarter of 2025 on March 24, 2026.

The players

Congress Asset Management Co.

An investment management firm that owns a $157.32 million stake in Boston Scientific Corporation.

Boston Scientific Corporation

A global medical device company that develops and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing shifts in institutional ownership of Boston Scientific stock, which can provide insights into broader market sentiment around the company and its performance.